Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Dr. Alen Salerian, Well-Known D.C. Psychiatrist, Invites Public Debate On Treatment Of Patients With Mental And Physical Pain

The following issued by Sanford Heisler, LLP, counsel for Dr. Salerian


News provided by

Sanford Heisler, LLP

Jul 01, 2013, 05:09 ET

Share this article

Share toX

Share this article

Share toX

WASHINGTON, July 1, 2013 /PRNewswire/ -- The District of Columbia Board of Medicine today published an Opinion revoking the medical license of a well-known psychiatrist, Dr. Alen J. Salerian.  The Board has determined that Dr. Salerian's prescriptions of certain narcotics in certain dosages fell outside the relevant standard of care. 

David Sanford of Sanford Heisler, LLP in Washington, D.C., said that "Dr. Salerian will appeal the Board of Medicine decision and we are confident that the D.C. Court of Appeals will overturn it."

Dr. Salerian has been a tireless advocate during his nearly 40-year career for improving the quality of life for his mental health and pain patients.  Dr. Salerian received his license to practice medicine in the District in 1974, completing his psychiatric residency as Chief Resident at GW in 1976 and serving as an Assistant Clinical Professor at GW for 26 years.  Dr. Salerian also worked at the Psychiatric Institute of Washington as the Chair of the Patient Care Evaluation Committee; as an Associate Medical Director; and as investigator for the Clinical Trial Unit.  Most recently, Dr. Salerian founded and practiced as a psychiatrist at the Salerian Center for Neuroscience and Pain to treat those with pain and psychiatric illnesses.

Dr. Salerian founded the non-profit Doctors for Equal Rights for People with Mental and Physical Pain.  Dr. Salerian also has been a reviewer of pain issues for the New England Journal of Medicine; an opinion leader for the FDA; a consultant to the FBI in numerous matters; a leader in performing transcranial magnetic stimulation; and a pioneer in neuroscience with scholarly contributions in peer reviewed journals.  Dr. Salerian has been at the forefront in discoveries relating to Alzheimer's and depression.

Dr. Salerian is a humanitarian who has provided medical services for free or for a greatly reduced fee to low income patients and has addressed pain and mental health issues for patients in low-income areas like Southwest Virginia.

DEA Raid of Dr. Salerian's Home and Office

In March 2011, the DEA raided Dr. Salerian's office and home.  During these raids, Dr. Salerian's wife and daughter were shackled and restrained for hours in violation of their constitutional rights.  Dr. Salerian's rights were violated as well;  and he alleges that he was not permitted to consult his attorneys and his property, including patients' medical records and his bank accounts and cars, were seized without ever being returned.  

This experience has caused major trauma and damage to Dr. Salerian's family and to his professional and public reputation.  His family is suffering physically and emotionally from the stress of these past two years. 

As a result of the government investigation, Dr. Salerian's patients were unable to fill their prescriptions at national pharmacy chains.  During the raid of Dr. Salerian's office, his patients were subjected to indignities and violations of their privacy.  Patients consequently suffered and felt humiliated, unable to acquire vitally needed medication to treat pain and mental illness.  As a consequence of the government raid, investigation, and hostilities directed to Dr. Salerian's patients, Dr. Salerian has shut down his practice and filed for bankruptcy protection.

Dr. Salerian commented, "I believe in the sanctity of the doctor-patient relationship.  Physical and mental pain patients should not be treated as second-class citizens." 

Four Aspects of This Story that Demand Public Attention and Comment

1.      Misuse of Drug Kingpin Statute

First, Dr. Salerian's assets were seized under a federal statute, The Comprehensive Crime Control Act of 1984 ("CCCA").  The CCCA was signed into law by President Ronald Reagan.  The goal of the CCCA was to disable drug-trafficking organizations with criminal forfeiture being used as a weapon to pursue powerful, large-scale,  and violent drug traffickers.  The CCCA armed the government with a tool designed to dismantle the economic power base of criminal organizations.  As noted by then-Senator Al D'Amato, "The goal of our legislation . . . is nothing less than stripping the drug kingpins of their drug-profit empires."  The goal was certainly not to target well-respected practicing psychiatrists treating pain and mental health patients. 

2.     Nationally Distinguished Experts Support Dr. Salerian

Second, two nationally distinguished experts, Dr. J. Alexander Bodkin and Dr. Richard Bonfiglio, testified on behalf of Dr. Salerian. Both testified that Dr. Salerian's methods met the standard of care for a psychiatrist treating patients for pain.  Dr. Bodkin teaches psychopharmacology at Harvard Medical School and has been the Head of the Ethics Committee of Harvard's teaching hospital for 15 years.  Dr. Bonfiglio is board certified in physical medicine and rehabilitation and has practiced in those fields for 31 years; is a faculty member at Temple Medical School; has written extensively in the field of pain management; and has qualified as an expert approximately 300 times. 

In stark contrast, the government's experts were not qualified to offer an opinion regarding Dr. Salerian's prescription practices.  Dr. Robert Dupont does not specialize in treating depression or pain management, and he has not done any clinical trials relating to pain.  Dr. Rafael Miguel is an anesthesiologist.  He is neither a psychiatrist, nor an addiction expert, nor an expert on depression.  Despite Dr. Bodkin's and Dr. Bonfiglio's impressive and unchallenged credentials, the Board credited the Government's experts and gave no credence to the actual subject matter experts who testified.

3.     Governmental Intrusion into the Sanctity of the Doctor-Patient Relationship

Third, the Board reached its conclusion after obtaining confidential medical information without the knowledge or consent of many of those patients.  Dr. Salerian has the highest regard for the Hippocratic Oath, which holds, in part, that doctors are to "respect the privacy of [their] patients, for their problems are not disclosed to [the doctor] that the world may know."  In tension with the basic principle governing doctors, the government reviewed countless patient files and, to this day, many of those patients are unaware of this governmental intrusion.

4.     Possible Criminal Negligence by the D.C. Department of Health

Fourth, restricting Dr. Salerian's privileges to prescribe narcotics to pain and mental health patients without concurrently instituting or overseeing a phased withdrawal program for the patients led to the disruption of responsible patient care.  That disruption resulted in catastrophic consequences for many of Dr. Salerian's patients. 

Dr. Salerian alerted the government to potential catastrophic consequences at the National Press Club in October 2012.  An NIH study served as a basis for those same concerns.  The government should investigate whether, in fact, the D.C. Department of Health engaged in criminal negligence by not heeding the warnings of Dr. Salerian and the NIH. 

Dr. Salerian concluded:  "The right of patients to be treated with dignity, care, and compassion is more important than my own career."

Media Contact: Jamie Moss, newsPRos, 1-201-493-1027, [email protected]

SOURCE Sanford Heisler, LLP

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.